ag

agilon health

AGL
NYSE
$93.88

Does agilon health have high-quality management?

Leadership reset: Tim O’Rourke was appointed CEO effective May 7, 2026, with former Aetna CEO Ron Williams continuing as Chair. 2026 guidance discipline and Q2 execution are encouraging, but the leadership team’s long‑term capital allocation record at agilon is still being established.

We view governance improvements and operating rigor positively, yet we need multi‑year evidence of stable medical margin and cash conversion before scoring higher.